In this regard, imatinib blocks the Slug (Snail2) expression in cancer cells [31], suggesting that the CMDV may induce EndMT by multiple pathways, some of which may be imatinib-sensitive while others are imatinib-insensitive. The gene discussed is SNAI2; the disease is cancer.